NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹325 Cr | ₹278 Cr | ₹257 Cr | ₹217 Cr | ₹198 Cr |
What is the latest Profit & Loss Account Balance ratio of NGL FINECHEM ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹325 Cr |
| Mar2025 | ₹278 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹217 Cr |
| Mar2022 | ₹198 Cr |
How is Profit & Loss Account Balance of NGL FINECHEM Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹325 Cr | 16.95 | |
| Mar2025 | ₹278 Cr | 7.85 | |
| Mar2024 | ₹257 Cr | 18.45 | |
| Mar2023 | ₹217 Cr | 9.77 | |
| Mar2022 | ₹198 Cr | - | |
Compare Profit & Loss Account Balance of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,780.0 Cr | -8.2% | 5.5% | 96.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,466.0 Cr | -0.8% | -5.1% | 6.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,222.0 Cr | -3.2% | -1.4% | 53.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | -1.6% | -6% | 32.1% | Stock Analytics | |
| CIPLA | ₹107,447.0 Cr | 0% | -3.6% | -13.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,471.0 Cr | 3.1% | 8.7% | -1.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -8.2% |
5.5% |
96.4% |
| SENSEX | -0.1% |
-2.3% |
-10.7% |
You may also like the below Video Courses